Home
>
National Drug Code (NDC)
>
Propylthiouracil
Propylthiouracil - 42291-550-01 - (Propylthiouracil)
Drug Information of Propylthiouracil
| Product NDC: | 42291-550 |
| Proprietary Name: | Propylthiouracil |
| Non Proprietary Name: | Propylthiouracil |
| Active Ingredient(s): | 50 mg/1 & nbsp; Propylthiouracil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Propylthiouracil
| Product NDC: | 42291-550 |
| Labeler Name: | AvKARE, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA080154 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970101 |
Package Information of Propylthiouracil
| Package NDC: | 42291-550-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (42291-550-01) |
NDC Information of Propylthiouracil
| NDC Code | 42291-550-01 |
| Proprietary Name | Propylthiouracil |
| Package Description | 100 TABLET in 1 BOTTLE (42291-550-01) |
| Product NDC | 42291-550 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Propylthiouracil |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19970101 |
| Marketing Category Name | ANDA |
| Labeler Name | AvKARE, Inc. |
| Substance Name | PROPYLTHIOURACIL |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA] |
